ATA12282000A - Galenische formulierungen - Google Patents

Galenische formulierungen

Info

Publication number
ATA12282000A
ATA12282000A AT12282000A AT12282000A ATA12282000A AT A12282000 A ATA12282000 A AT A12282000A AT 12282000 A AT12282000 A AT 12282000A AT 12282000 A AT12282000 A AT 12282000A AT A12282000 A ATA12282000 A AT A12282000A
Authority
AT
Austria
Prior art keywords
galenic formulations
galenic
formulations
Prior art date
Application number
AT12282000A
Other languages
English (en)
Other versions
AT408520B (de
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939310974A external-priority patent/GB9310974D0/en
Priority claimed from GB939320463A external-priority patent/GB9320463D0/en
Priority claimed from AT0106594A external-priority patent/AT408521B/de
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Priority to AT12282000A priority Critical patent/AT408520B/de
Publication of ATA12282000A publication Critical patent/ATA12282000A/de
Application granted granted Critical
Publication of AT408520B publication Critical patent/AT408520B/de

Links

AT12282000A 1993-05-27 2000-07-14 Galenische formulierungen AT408520B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT12282000A AT408520B (de) 1993-05-27 2000-07-14 Galenische formulierungen

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939310974A GB9310974D0 (en) 1993-05-27 1993-05-27 Organic compounds
GB939320463A GB9320463D0 (en) 1993-10-05 1993-10-05 Organic compounds
AT0106594A AT408521B (de) 1993-05-27 1994-05-25 Pharmazeutische orale zusammensetzung enthaltend verbindungen der rapamycinklasse
AT12282000A AT408520B (de) 1993-05-27 2000-07-14 Galenische formulierungen

Publications (2)

Publication Number Publication Date
ATA12282000A true ATA12282000A (de) 2001-05-15
AT408520B AT408520B (de) 2001-12-27

Family

ID=27421435

Family Applications (1)

Application Number Title Priority Date Filing Date
AT12282000A AT408520B (de) 1993-05-27 2000-07-14 Galenische formulierungen

Country Status (1)

Country Link
AT (1) AT408520B (de)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US5206018A (en) * 1978-11-03 1993-04-27 Ayerst, Mckenna & Harrison, Inc. Use of rapamycin in treatment of tumors
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US4987139A (en) * 1989-05-05 1991-01-22 Merck & Co., Inc. FK-520 microbial transformation product
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
GB8925797D0 (en) * 1989-11-15 1990-01-04 Fisons Plc Compositions
KR0177158B1 (ko) * 1990-03-01 1999-03-20 후지사와 도모기찌로 면역억제 활성을 갖는 트리사이클릭 화합물 함유 용액 제제
WO1991019495A1 (en) * 1990-06-11 1991-12-26 Fujisawa Pharmaceutical Co., Ltd. Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease
US5190950A (en) * 1990-06-25 1993-03-02 Merck & Co., Inc. Antagonists of immunosuppressive macrolides
GB2247620A (en) * 1990-09-07 1992-03-11 Fujisawa Pharmaceutical Co The use of macrolide compounds for cytomegalovirus infection
GB2248184A (en) * 1990-09-28 1992-04-01 Fujisawa Pharmaceutical Co New use of macrolide compounds for active oxygen-mediated diseases
GB2249027A (en) * 1990-10-23 1992-04-29 Fujisawa Pharmaceutical Co Use of macrolide compounds for hepatic failure
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
JPH06502659A (ja) * 1991-05-31 1994-03-24 ファイザー　インク 免疫抑制剤としてのラパマイシンプロドラッグの使用
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
ZA924953B (en) * 1991-07-25 1993-04-28 Univ Louisville Res Found Method of treating ocular inflammation
US5169851A (en) * 1991-08-07 1992-12-08 American Home Products Corporation Rapamycin analog as immunosuppressants and antifungals
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease

Also Published As

Publication number Publication date
AT408520B (de) 2001-12-27

Similar Documents

Publication Publication Date Title
NO934009D0 (no) Farmasoeytiske formuleringer
DE69423670D1 (de) Siloxy-aluminoxan-Zusammensetzungen
EE9800123A (et) Stabiilsed lüofiliseeritud ravimvormid
NO920987D0 (no) Farmasoeytiske aerosolformuleringer
BR9508767A (pt) Formulações tensoativas
DE69417381T2 (de) Zahnpflegemittel
ITTV930002A0 (it) Struttura di pattino perfezionato
MA22220A1 (fr) Formulations gelifiees
NO933467D0 (no) Ioderte aroyloksykarboksamider
DE69305413T2 (de) Pulverisierungsvorrichtung
GB9410252D0 (en) Galenic formulations
ITMI951395A0 (it) Formulazioni di f-silicone
LV10563A (lv) Konservantu sastavi
BR9307800A (pt) ComposiçÕes anticárie
ID16781A (id) Formulasi-formulasi farmasi
ITMI941169A0 (it) Formulazioni farmaceutiche
DE69430362T2 (de) Ektoparasitizide formulierung
DK0599461T3 (da) Hærdelige sammensætninger
ATA12282000A (de) Galenische formulierungen
DE9302853U1 (de) Schubriegel
DK88093D0 (da) Stabilt praeparat
DK103393D0 (da) Praeparat
BR1100596A (pt) Composto e formulações farmacêuticas
DE69333526D1 (de) Dermatologische zusammensetzung
LV10417A (lv) Plaksnisu kede

Legal Events

Date Code Title Description
MM01 Lapse because of not paying annual fees

Effective date: 20120515